NORTHWEST BIOTHERAPEUTICS INC

Profile

Company Names

NORTHWEST BIOTHERAPEUTICS INC

Addresses

4800 MONTGOMERY LANE, SUITE 800, BETHESDA, MD 20814

4800 MONTGOMERY LANE,, SUITE 800, BETHESDA, MD 20814

4800 MONTGOMERY LANE, SUITE 800, BETHESDA, MD 20814

Phone Numbers

240-497-9024

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$11,327,000.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2020-08-28 
$0.00 
$2,590,203.00 
$2,590,203.00 
 
4
2017-12-29 
$880,000.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2017-05-02 
$52,000.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2016-02-29 
$10,000,000.00 
$10,000,000.00 
$0.00 
 
1
2010-11-29 
$395,000.00 
$395,000.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUSAN 
 
BAYH 
DIRECTOR
COFER 
 
BLACK 
DIRECTOR
COFER 
BLACK 
DIRECTOR
MARNIX 
 
BOSCH 
EXECUTIVE OFFICER
MARNIX 
BOSCH 
EXECUTIVE OFFICER
ALTON 
BOYNTON 
EXECUTIVE OFFICER, DIRECTOR
ALTON 
L. 
BOYNTON 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
FARMER 
DIRECTOR
ROBERT 
FARMER 
DIRECTOR
ROBERT 
A. 
FARMER 
DIRECTOR
LESLIE 
GOLDMAN 
EXECUTIVE OFFICER
JERRY 
 
JASINOWSKI 
DIRECTOR
JERRY 
JASINOWSKI 
DIRECTOR
NAVID 
 
MALIK 
DIRECTOR
LINDA 
POWERS 
EXECUTIVE OFFICER, DIRECTOR
LINDA 
F. 
POWERS 
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
 
2020-08-28 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-12-29 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-02 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
 
2016-02-29 
D/A
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-11-29 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-11-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT
375
NONE
NONE
JM BRYANT CAPITAL PARTNERS, PRIVATE CO. OF LAIDLAW + COMPANY
NONE